Most Popular at Psychiatrist.com (updated monthly)

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

[Abstract]

Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials

[Abstract]

Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care [CME]

[Abstract]

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

[Abstract]

Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice [Free Access]

[Full Text]

Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

[Abstract]

Association of Hypnotics With Stroke Risk: A Population-Based Case-Control Study

[Abstract]

Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review

[Abstract]

New Treatment Targets to Improve Symptoms in Schizophrenia [CME]

[Activity]

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder [CME]

[Activity]